Jane Kim
About Jane Kim
Jane Kim is the Director at BeiGene, with extensive experience in regulatory affairs and project management in the pharmaceutical and biotech industries.
Current Role at BeiGene
Jane Kim serves as a Director at BeiGene, a prominent biopharmaceutical company. In her role, she contributes to the advancement of pharmaceutical and biotech products through effective regulatory strategies and operations. Her leadership plays a crucial role in navigating the complex landscape of drug development and regulatory compliance.
Previous Experience at Pharmacyclics
From 2017 to 2020, Jane Kim held the position of Associate Director at Pharmacyclics, an AbbVie Company. During her three-year tenure, she was instrumental in leading regulatory initiatives and overseeing critical projects that enhanced the company's compliance and operational efficiencies within the pharmaceutical sector.
Role at CSC
Jane Kim spent seven years at CSC (2010-2017) as Senior Regulatory Engagement Manager. She played a pivotal role in managing regulatory engagements, ensuring that the company's pharmaceutical products met the necessary standards and guidelines required for approval by global regulatory bodies.
Educational Background
Jane Kim studied at The Johns Hopkins University, one of the leading institutions for higher learning. Her academic experience provided a strong foundation in the regulatory and pharmaceutical fields, equipping her with the knowledge and skills needed to excel in her professional career.
Regulatory Approvals and Consultations
Jane Kim has overseen more than 90 applications to the FDA, Health Canada, and the European Medicines Agency. Her extensive work has significantly contributed to regulatory approvals across the pharmaceutical and biotech industries. Additionally, she has consulted for top-tier companies, enhancing organizational performance during new product development processes.
Project Management and Execution
Throughout her career, Jane Kim has executed multi-million dollar projects for companies in the US, Canada, Europe, and Asia. Her strategic oversight and management skills have ensured the successful delivery of complex projects, contributing to the growth and innovation of the pharmaceutical and biotech sectors.